Position in GMAB
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$1,727,530
+$346,551 QoQ
Shares Held
64,388
+43.6% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GMAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Dorsey Wright & Associates holds $27,982,368 across 7 Biotechnology names. GMAB ranks #5 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
577,147 | $15,986,971 | |
| 2 | ASND |
Ascendis Pharma A/S
|
11,879 | $2,717,083 | |
| 3 | ABVX |
Abivax S.A.
|
23,452 | $2,611,380 | |
| 4 | DBVT |
DBV Technologies S.A.
|
102,550 | $2,142,269 | |
| 5 | GMAB |
Genmab A/S
This page
|
64,388 | $1,727,530 | |
| 6 | ARGX |
Argenx SE
|
2,189 | $1,598,517 | |
| 7 | INCY |
Incyte Corp
|
12,735 | $1,198,618 |
All Filings in GMAB
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,727,530 | 64,388 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $1,380,979 | 44,837 | Shares | Sole | 2026-02-20 | |
| 2022-12-31 | $3,706,173 | 87,451 | Shares | Sole | 2023-02-14 | |
| 2021-12-31 | $4,202,814 | 106,239 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $4,838,026 | 110,710 | Shares | Sole | 2021-10-26 | |
| 2020-12-31 | $3,442,844 | 84,674 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $3,166,837 | 86,502 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $2,892,002 | 85,335 | Shares | Sole | 2020-07-23 | |
| No filing history on record for this holder in this stock. | ||||||